Caris Life Sciences, Inc.Caris Life Sciences, Inc.Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

No trades
See on Supercharts

Price target

39.440.000.00%
The 9 analysts offering 1 year price forecasts for CAI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to CAI in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CAI EPS for the last quarter is −7.97 USD despite the estimation of −0.22 USD. In the next quarter EPS is expected to reach −0.17 USD. Track more of Caris Life Sciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Caris Life Sciences, Inc. revenue is expected to reach ‪173.14 M‬ USD. Check out Caris Life Sciences, Inc. revenue and earnings and make informed decisions.
According to analysts, CAI price target is 39.44 USD with a max estimate of 45.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch Caris Life Sciences, Inc. stock price chart and keep track of the current situation with CAI news and stock market news.
We've gathered opinions of 9 analysts rating CAI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.